Esomeprazole and omeprazole may possibly enhance the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about increased adverse effects including drowsiness, although the clinical relevance is reduced in most patients – monitor the patient for adverse effects (e. If affected person simply cannot resume their common o